NSC |
Compound |
Enrichment |
Correlation |
NSC 689222 |
Null |
0.000573863872925603 |
0.23882559 |
NSC 104801 |
Cytembena |
0.000610795106687085 |
0.34733412 |
NSC 132791 |
Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo |
0.000610795106687085 |
0.37512183 |
NSC 624191 |
Null |
0.000610795106687085 |
0.41004438 |
NSC 641055 |
Null |
0.000610795106687085 |
0.43826208 |
NSC 661428 |
Null |
0.000610795106687085 |
0.44591815 |
NSC 664266 |
Null |
0.000610795106687085 |
0.58070732 |
NSC 753193 |
N-(2-(4-acetylpiperazin-1-yl)ethyl)-3-(3-chloro-5-hydroxyphenyl)-4-(pyridin-4-yl)-1H-pyrazole-1-carboxamide |
0.000967118311825465 |
0.27504828 |
NSC 165572 |
Pyrido[3,2-g]quinoline-2,5,8,10(1H,9H)-tetrone, 1,4,6-trimethyl- |
0.000967118311825486 |
0.040994258 |
NSC 670283 |
2,2'-Spirobi[2H-benz[f]indene]-5,5'-dione, 1,1',3,3',5,5',6,6',7,7',8,8'-dodecahydro- |
0.000967118311825486 |
0.42537064 |